Neoadjuvant immune checkpoint inhibitors in cancer, current state of the art-Reference-Cited by-同舟云学术

Neoadjuvant immune checkpoint inhibitors in cancer, current state of the art

Published:2021-01 Issue: Volume:157 Page:103172
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Le Saux Olivia,Lounici Yasmine,Wajda Pauline,Barrin Sarah,Caux Christophe,Dubois Bertrand,Ray-Coquard Isabelle

Funder

Novartis, Lilly, MSD and Astrazeneca

Novartis, Foundation Hospira-Pfizer

Astellas

MSD;

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference72 articles.

1. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma;Amaria;Nat. Med.,2018

2. Combining Atezolizumab With Neoadjuvant Chemotherapy Does Not Improve Pathologic Complete Response Rates for Patients With Triple- Negative Breast Cancer;Antonio,2020

3. Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer;Bindea;Immunity,2013

4. Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trial;Carthon;Clin. Cancer Res.,2010

5. The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome;Caswell;BMC Med.,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances of ultrasound in tumor immunotherapy;International Immunopharmacology;2024-06

2. Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer;Oncogene;2023-09-21

3. Macrophage Reprogramming via the Modulation of Unfolded Protein Response with siRNA-Loaded Magnetic Nanoparticles in a TAM-like Experimental Model;Pharmaceutics;2023-06-12

4. Management of Cancer-Associated Myositis;Current Treatment Options in Rheumatology;2022-10-21

5. The use of oncolytic virotherapy in the neoadjuvant setting;Journal for ImmunoTherapy of Cancer;2022-04